Ledger.Open graph →
SEC Form D · Amendment · filed October 4, 2012

Peloton Therapeutics, Inc

Offering
$20.0M
Sold
$11.7M
Exemption
—
Industry
Biotechnology
Location
DALLAS, TX
Type
—

People & firms on this filing (9)

James A. Huang · Warrington, PAExec · DirectorMichael Brown · VANCOUVER, British Columbia, CanadaDirectorJohn Creecy · Dallas, TXDirectorMark H. Handfelt · Seattle, WAExec · DirectorMichael Brown · New York, NYDirectorDavid Goeddel · San Francisco, CADirectorJohn Creecy · Helotes, TXDirectorBrett Ringle · Dallas, TXDirectorJohn Josey · Dallas, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗